Literature DB >> 19918339

Hypocitraturia: pathophysiology and medical management.

Jack M Zuckerman1, Dean G Assimos.   

Abstract

Low urinary citrate excretion is a known risk factor for the development of kidney stones. Citrate inhibits stone formation by complexing with calcium in the urine, inhibiting spontaneous nucleation, and preventing growth and agglomeration of crystals. Hypocitraturia is a common metabolic abnormality found in 20% to 60% of stone formers. It is most commonly idiopathic in origin but may be caused by distal renal tubular acidosis, hypokalemia, bowel dysfunction, and a high-protein, low-alkali diet. Genetic factors, medications, and other comorbid disorders also play a role. Hypocitraturia should be managed through a combination of dietary modifications, oral alkali, and possibly lemonade or other citrus juice-based therapy. This review concerns the pathophysiology of hypocitraturia and the management of stone formers afflicted with this abnormality.

Entities:  

Keywords:  Alkali citrate; Citrate metabolism; Citrate pathophysiology; Citrus juice; Hypocitraturia; Hypocitraturia etiologies; Lemonade; Medical management of stone disease; Potassium citrate

Year:  2009        PMID: 19918339      PMCID: PMC2777061     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  111 in total

1.  The excretion of organic anion in renal tubular acidosis with particular reference to citrate.

Authors:  R E DEDMON; O WRONG
Journal:  Clin Sci       Date:  1962-02       Impact factor: 6.124

2.  The effects of changes in acid-base balance on urinary citrate in the rat.

Authors:  M A CRAWFORD; M D MILNE; B H SCRIBNER
Journal:  J Physiol       Date:  1959-12       Impact factor: 5.182

3.  Effect of acetazolamide on citrate excretion and formation of renal calculi.

Authors:  E E GORDON; S G SHEPS
Journal:  N Engl J Med       Date:  1957-06-27       Impact factor: 91.245

4.  The effect of fruits and vegetables on urinary stone risk factors.

Authors:  Tiziana Meschi; Umberto Maggiore; Enrico Fiaccadori; Tania Schianchi; Simone Bosi; Giuditta Adorni; Erminia Ridolo; Angela Guerra; Franca Allegri; Almerico Novarini; Loris Borghi
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

5.  The formation of citric and alpha-ketoglutaric acids in the mammalian body.

Authors:  H A Krebs; E Salvin; W A Johnson
Journal:  Biochem J       Date:  1938-01       Impact factor: 3.857

6.  Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.

Authors:  Clarita V Odvina; Ralph P Mason; Charles Y C Pak
Journal:  Am J Ther       Date:  2006 Mar-Apr       Impact factor: 2.688

7.  Genetic and dietary factors in urinary citrate excretion.

Authors:  Ojas Shah; Dean G Assimos; Ross P Holmes
Journal:  J Endourol       Date:  2005-03       Impact factor: 2.942

8.  Ethnic background has minimal impact on the etiology of nephrolithiasis.

Authors:  Michaella E Maloney; W Patrick Springhart; Wesley O Ekeruo; Matthew D Young; Chibuzo U Enemchukwu; Glenn M Preminger
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

Review 9.  Preventive treatment of nephrolithiasis with alkali citrate--a critical review.

Authors:  D Mattle; B Hess
Journal:  Urol Res       Date:  2005-05-04

10.  Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.

Authors:  Xiaoxia Sheng; Taesung Jung; Jeffrey A Wesson; Michael D Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

View more
  60 in total

1.  Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Fernando Gianfrancesco; Riccardo Muscariello; Michele Schiano di Cola; Pasquale Strazzullo; Teresa Esposito
Journal:  J Nephrol       Date:  2016-09-17       Impact factor: 3.902

2.  Probiotics for prevention of urinary stones.

Authors:  John C Lieske
Journal:  Ann Transl Med       Date:  2017-01

3.  Medical evaluation and management of urolithiasis.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  Ther Adv Urol       Date:  2010-02

4.  Urinary evaluation after RYGBP: a lithogenic profile with early postoperative increase in the incidence of urolithiasis.

Authors:  Antonio Carlos Valezi; Paulo Emilio Fuganti; Jorge Mali Junior; Vinicius Daher Delfino
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

5.  Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion.

Authors:  Ernest I Mandel; Eric N Taylor; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

6.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

Review 7.  Diet: from food to stone.

Authors:  Justin I Friedlander; Jodi A Antonelli; Margaret S Pearle
Journal:  World J Urol       Date:  2014-06-18       Impact factor: 4.226

8.  Proton-pump inhibitors associated with decreased urinary citrate excretion.

Authors:  Parth M Patel; Alexander M Kandabarow; Eseosa Aiwerioghene; Enrique Blanco-Martinez; Spencer Hart; David J Leehey; Ahmer Farooq; Kristin G Baldea; Thomas M T Turk
Journal:  Int Urol Nephrol       Date:  2020-11-18       Impact factor: 2.370

Review 9.  Acidosis and Urinary Calcium Excretion: Insights from Genetic Disorders.

Authors:  R Todd Alexander; Emmanuelle Cordat; Régine Chambrey; Henrik Dimke; Dominique Eladari
Journal:  J Am Soc Nephrol       Date:  2016-07-28       Impact factor: 10.121

10.  Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.

Authors:  Concepción Sáez-Torres; Félix Grases; Dolores Rodrigo; Ana María García-Raja; Cristina Gómez; Guillem Frontera
Journal:  Pediatr Nephrol       Date:  2012-12-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.